Literature DB >> 5902271

The development of bilateral adenomatous adrenal hyperplasia in a case of Cushing's syndrome of eighteen years' duration.

M E Levin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5902271     DOI： 10.1016/0002-9343(66)90112-4

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  9 in total

1.  Cushing's syndrome due to ACTH-independent bilateral adrenocortical macronodular hyperplasia.

Authors:  M Terzolo; A Boccuzzi; A Ali; E Bollito; C De Risi; P Paccotti; A Angeli
Journal:  J Endocrinol Invest       Date:  1997-05       Impact factor: 4.256

Review 2.  Autosomal dominant transmission of the NAME syndrome (nevi, atrial myxoma, mucinosis of the skin and endocrine overactivity).

Authors:  R J Koopman; R Happle
Journal:  Hum Genet       Date:  1991-01       Impact factor: 4.132

3.  Primary pigmented micronodular disease of the adrenals.

Authors:  P Limone; M Maccario; R Vigliani; G Isaia; F Massara; G M Molinatti
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

Review 4.  Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes.

Authors:  C A Stratakis
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

5.  Cushing's syndrome with nodular adrenal hyperplasia.

Authors:  H S Tucker; H L Estep; D M Hume; M Vinik; S Kay
Journal:  Trans Am Clin Climatol Assoc       Date:  1969

6.  Primary adrenocortical nodular dysplasia with Cushing's syndrome and cardiac myxomas. A peculiar familial disease.

Authors:  M Schweizer-Cagianut; F Salomon; C E Hedinger
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

7.  "Syndrome myxoma": a subset of patients with cardiac myxoma associated with pigmented skin lesions and peripheral and endocrine neoplasms.

Authors:  H J Vidaillet; J B Seward; F E Fyke; W P Su; A J Tajik
Journal:  Br Heart J       Date:  1987-03

8.  Marked elevation of serum dehydroepiandrosterone sulphate in Cushing's disease with macronodular adrenocortical hyperplasia.

Authors:  J A Jackson; J D Fachnie; R C Mellinger
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

Review 9.  Cushing's syndrome due to primary pigmented nodular adrenocortical disease--a case report reviews of the literature.

Authors:  K M Choi; J H Seu; Y H Kim; E J Lee; S J Kim; S H Baik; D S Choi
Journal:  Korean J Intern Med       Date:  1995-01       Impact factor: 2.884
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.